Neurocrine Biosciences: An Attractive Takeover Candidate with Potential >50% Upside.
FDA has accepted the New Drug Application (NDA) for Neurocrine Biosciences Inc (NBIX US) Valbenazine for the treatment of Tardive Dyskinesia (with...
576 Views
Taiyo Nippon Sanso - Next on Mitsubishi Chem's List? Possibly Not
Shares in Taiyo Nippon Sanso (TNS) gained ¥43 to ¥936 on the back on the Mitsubishi Chemical bid for Nippon Synthetic. The situation is not...
723 Views